Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.


This study examines whether hospital admission and discharge are associated with increased risk of opioid-related death.

Original research | 2021
Overdose, Mortality, About PWUD, Hospitals
Commentary | 2021
Harm reduction, Policy/Regulatory, Barriers and enablers, Peer/PWLLE program involvement, SCS/OPS, Hospitals
Guidelines | 2020
Clinical guidance, Advocacy, Barriers and enablers, Hospitals, About prescribers

This analysis used U.S. Drug Enforcement Administration (DEA) data to address two questions: (1) To what extent does illegally manufactured fentanyl (IMF) supply vary over time and geography?

Original research | 2022
Drug checking, Illegal drugs

This review aimed to examine the impact and acceptability of community-based models of alcohol and other drug (AOD) support for First Nations adults in Australia.

Lit review | 2022
Indigenous, Wrap-around services
Video | 2022
Hospitals, Stigma, Policy/Regulatory, Harm reduction

We designed this study to analyze the prevalence, nature, and context of beliefs about naloxone and overdose among U.S. laypersons.

Original research | 2022
Overdose, Advocacy

We evaluated: (1) punitive prenatal substance use policies (PSUPs) criminalizing prenatal substance use or defining it as child maltreatment; (2) supportive PSUPs granting pregnant females priority

Original research | 2022
Parents/caregivers, Policy/Regulatory, About PWUD, Barriers and enablers, Sex/Gender

People admitted to compulsory care are known to suffer high mortality risks, but whether the risk of dying is further heightened immediately after discharge is not known.

Original research | 2022
Transitions in care/treatment, About PWUD, Mortality, Policy/Regulatory, Outcomes

The purpose of this study was to qualitatively assess how efforts to increase access to buprenorphine via telehealth are implemented by prescribers and pharmacists and experienced by patients.

Original research | 2022
Policy/Regulatory, About PWUD, About pharmacists, Barriers and enablers, Transitions in care/treatment, Digital health, Stigma

In 2017, the Good Samaritan Drug Overdose Act (GSDOA) was enacted, to encourage people to contact emergency medical services by providing bystanders at the scene of an overdose with legal protectio

Original research | 2022
Overdose, Justice system/law enforcement, Policy/Regulatory, Equity, Decriminalization/legalization, Barriers and enablers

No studies to date have described PWUD's perspectives from a real-world setting about ideal fentanyl test strip (FTS) program characteristics.

Original research | 2022
Drug checking, Illegal drugs, About PWUD, Harm reduction

The aim of this study is to explore caregivers’ experiences accessing opioid use treatments with young people and their needs and ideas for improving such treatments.

Original research | 2022
Youth, Illegal drugs, Parents/caregivers, Policy/Regulatory

It is critical to develop empirically based, community-treatment friendly, psychotherapy interventions to improve treatment for patients with comorbid chronic pain and Opioid Use Disorder.

Original research | 2022
About PWUD, Chronic pain

We describe self-reported challenges obtaining prescription opioids among people prescribed opioids long-term for chronic non-cancer pain (CNCP) and explore associations with participant and treatm

Original research | 2022
Chronic pain, About PWUD

We assessed the effects of COVID-19-related changes on take-home methadone dosing in two opioid treatment programs serving five rural Oregon counties.

Original research | 2022
Policy/Regulatory, About PWUD, Outcomes, Illegal drugs, Substitution

The goal of this study was to identify provider factors that could drive differences in treatment retention while accounting for the contribution of patient characteristics to retention.

Original research | 2022
Equity, About prescribers, Barriers and enablers, Outcomes
Commentary | 2022
Harm reduction, Policy/Regulatory, Barriers and enablers, About PWUD, Illegal drugs, Youth, SCS/OPS

This study examined disparities in years of potential life lost (YPLL) related to opioid use among racial and ethnic groups adjusting for individual- and neighborhood-level characteristics.

Original research | 2022
Overdose, Mortality, About PWUD, Equity

This study evaluated factors associated with 60-day adherence to novel opioid alternatives prescribed at an inner-city health centre in Victoria, Canada.

Original research | 2022
Mental health, About PWUD, Safer supply, Evidence base, Outcomes

Refine Your Search